Anticoagulant & Blood Thinner Malpractice: Heparin and Warfarin Errors

What Are Anticoagulants and Why Are They Dangerous?

Anticoagulants are medications that prevent the blood from clotting. They are used to prevent and treat blood clots in conditions such as:

• Deep vein thrombosis (DVT): Blood clots in the deep veins, usually in the legs. [Link to: /misdiagnosis/pulmonary-embolism-misdiagnosis]
• Pulmonary embolism (PE): Blood clots in the lungs.
• Atrial fibrillation: An irregular heart rhythm that increases the risk of stroke. [Link to: /medical-malpractice/stroke-misdiagnosis]
• After certain surgeries: Particularly orthopedic surgeries (hip replacement, knee replacement). [Link to: /surgical-errors/orthopedic-surgery-malpractice]
• Mechanical heart valves: Which require lifelong anticoagulation. [Link to: /surgical-errors/cardiac-surgery-malpractice]

Why Anticoagulants Are Dangerous

Anticoagulants are dangerous because they increase the risk of bleeding. Too much anticoagulant can cause serious or fatal bleeding, including intracranial hemorrhage (bleeding in the brain), gastrointestinal bleeding, and retroperitoneal bleeding. Too little anticoagulant can allow blood clots to form, causing stroke, pulmonary embolism, or death.

The main types of anticoagulants include:

• Heparin (unfractionated heparin): A fast-acting anticoagulant given intravenously or subcutaneously. Used in hospitals for acute anticoagulation. Monitored with the aPTT (activated partial thromboplastin time) test.
• Low-molecular-weight heparin (LMWH): Enoxaparin (Lovenox), dalteparin (Fragmin). Given subcutaneously. Does not require routine monitoring.
• Warfarin (Coumadin, Jantoven): An oral anticoagulant. Monitored with the PT/INR (prothrombin time/international normalized ratio) test. Has a narrow therapeutic window and many drug and food interactions.
• Direct oral anticoagulants (DOACs): Apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa), edoxaban (Savaysa). Oral anticoagulants that do not require routine monitoring. [Link to: /dangerous-drugs/xarelto-lawsuit]

Common Anticoagulant Medication Errors

Anticoagulant medication errors can occur in several ways:

• Wrong dose: Administering too much anticoagulant (causing bleeding) or too little (causing clotting). This can result from decimal point errors, calculation errors, or failure to adjust for the patient weight or kidney function.
• Failure to monitor: Failing to monitor the patient aPTT (for heparin) or PT/INR (for warfarin) regularly. [Link to: /medical-malpractice/failure-to-monitor]
• Failure to adjust the dose: Failing to adjust the anticoagulant dose based on lab results.
• Wrong medication: Administering the wrong anticoagulant (e.g., heparin instead of LMWH).
• Look-alike/sound-alike errors: Confusing heparin and Hespan (a different IV fluid), or confusing different concentrations of heparin.
• Drug interactions: Failing to check for drug interactions that can increase or decrease the anticoagulant effect. [Link to: /medication-errors/wrong-drug-interaction]
• Failure to reverse: Failing to administer reversal agents (protamine for heparin, vitamin K or PCC for warfarin, idarucizumab for dabigatran, andexanet alfa for apixaban/rivaroxaban) when serious bleeding occurs.
• Failure to hold before procedures: Failing to hold anticoagulants before surgeries or procedures, causing excessive bleeding.
• Failure to resume after procedures: Failing to resume anticoagulants after procedures, causing blood clots.
• Medication reconciliation errors: Failing to reconcile the patient home anticoagulant regimen with the hospital regimen, causing duplicate dosing or missed doses.

Heparin Errors

Heparin is particularly dangerous because it is given intravenously and acts rapidly. Common heparin errors include:

• Wrong concentration: Heparin comes in different concentrations (e.g., 1,000 units/mL, 10,000 units/mL, 40,000 units/mL), and confusing them can cause serious overdose.
• Wrong infusion rate: Heparin is often given as a continuous IV infusion, and errors in the infusion rate can cause overdose or underdose.
• Failure to monitor aPTT: The standard of care requires regular aPTT monitoring and dose adjustment. [Link to: /medical-malpractice/failure-to-monitor]
• Failure to adjust for weight: Heparin dosing is weight-based, and errors in weight or calculation can cause significant dosing errors.
• Look-alike errors: Heparin vials can be confused with other medications, particularly in crash carts or ICU settings.
• Failure to reverse: Failing to administer protamine when serious bleeding occurs.

Warfarin (Coumadin) Errors

Warfarin is particularly dangerous because it has a narrow therapeutic window -- the difference between a therapeutic dose and a dangerous dose is very small. Common warfarin errors include:

• Wrong dose: Warfarin dosing is complex and must be adjusted based on the patient PT/INR. Errors in dosing can cause bleeding or clotting.
• Failure to monitor PT/INR: The standard of care requires regular PT/INR monitoring and dose adjustment. [Link to: /medical-malpractice/failure-to-monitor]
• Failure to adjust for drug interactions: Warfarin has many drug interactions, including antibiotics, antifungals, and NSAIDs. Failure to adjust for these interactions can cause bleeding or clotting. [Link to: /medication-errors/wrong-drug-interaction]
• Failure to adjust for dietary vitamin K: Warfarin interacts with dietary vitamin K (found in leafy green vegetables). Changes in diet can affect the warfarin effect.
• Failure to hold before procedures: Warfarin must be held before surgeries or procedures to prevent bleeding. Failure to hold can cause excessive bleeding.
• Failure to bridge: When warfarin is held for a procedure, the patient may need bridging with heparin or LMWH to prevent clotting.
• Failure to reverse: Failing to administer vitamin K, fresh frozen plasma, or prothrombin complex concentrate (PCC) when serious bleeding occurs.

Direct Oral Anticoagulant (DOAC) Errors

DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) are newer anticoagulants that do not require routine monitoring. However, errors can still occur:

• Wrong dose: DOAC dosing depends on the patient kidney function, weight, and age. Errors in dosing can cause bleeding or clotting.
• Failure to adjust for kidney function: DOACs are eliminated by the kidneys, and failure to adjust the dose for kidney impairment can cause overdose. [Link to: /medication-errors/hospital-overdose]
• Failure to check for drug interactions: DOACs have drug interactions, particularly with other medications that affect bleeding risk. [Link to: /medication-errors/wrong-drug-interaction]
• Failure to reverse: Failing to administer reversal agents (idarucizumab for dabigatran, andexanet alfa for apixaban/rivaroxaban) when serious bleeding occurs.

When Anticoagulant Errors Constitute Malpractice

An anticoagulant error constitutes medical malpractice in New York when a healthcare provider deviated from the accepted standard of care and that deviation caused harm. This includes:

• The provider administered the wrong dose of anticoagulant.
• The provider failed to monitor the patient lab values (aPTT for heparin, PT/INR for warfarin) regularly.
• The provider failed to adjust the anticoagulant dose based on lab results.
• The provider administered the wrong anticoagulant or the wrong concentration.
• The provider failed to check for drug interactions.
• The provider failed to hold anticoagulants before procedures or failed to resume them after.
• The provider failed to administer reversal agents when serious bleeding occurred.
• The provider failed to reconcile the patient home anticoagulant regimen with the hospital regimen.
• The deviation caused harm (serious bleeding, intracranial hemorrhage, stroke, pulmonary embolism, or death). [Link to: /brain-injury/lawyer] [Link to: /medical-malpractice/stroke-misdiagnosis]

Proving Your Anticoagulant Error Case

To prove an anticoagulant error case, you need:

• Medical records: Including physician orders, the Medication Administration Record (MAR), nursing notes, pharmacy records, laboratory results (aPTT, PT/INR), and imaging studies (CT, MRI for bleeding). [Link to: /resources/how-to-get-medical-records-for-a-lawsuit]
• The MAR: The MAR documents when and how much anticoagulant was administered, by whom, and whether the patient was monitored. Discrepancies between the MAR and the physician orders can prove the error.
• Laboratory results: aPTT levels (for heparin) and PT/INR levels (for warfarin) showing whether the patient was in the therapeutic range.
• Imaging studies: CT scans or MRIs showing bleeding (intracranial hemorrhage, gastrointestinal bleeding, retroperitoneal bleeding). [Link to: /radiology-errors/ct-scan-negligence]
• Expert review: Independent review by board-certified hematologists, hospital pharmacists, and critical care physicians.
• Standard of care evidence: Establishing what the standard of care requires for anticoagulant administration and monitoring.
• Causation evidence: Establishing that the anticoagulant error caused the harm (e.g., that the intracranial hemorrhage was caused by heparin overdose). [Link to: /delayed-diagnosis-lawyer/loss-of-chance]
• Expert testimony: From qualified experts.

New York Statute of Limitations

Anticoagulant error claims are subject to the 2.5-year statute of limitations for medical malpractice (CPLR 214-a), running from the date of the negligent act.

Key considerations:

• Date of the negligent act: The 2.5-year clock starts on the date of the anticoagulant error.
• Continuous treatment doctrine: If you continued to receive treatment from the same provider for the same condition, the statute may be extended.
• Municipal hospitals: If the error occurred at a municipal hospital (NYC Health + Hospitals), a notice of claim must be filed within 90 days. [Link to: /hospital-negligence/suing-nyc-h-h]
• Wrongful death: If the anticoagulant error caused death, the wrongful death claim must be filed within 2 years. [Link to: /wrongful-death-lawyer]

Common Defense Arguments and How We Counter Them

Defense: The patient had a complex medical condition that made bleeding inevitable.

Defense attorneys use several arguments in anticoagulant error cases:

• Our Counter: While complex medical conditions can increase the risk of bleeding, the standard of care requires providers to manage anticoagulants carefully, including monitoring lab values, adjusting doses, and checking for drug interactions. If the provider failed to follow these protocols, the standard of care was breached, regardless of the patient underlying condition.

Defense: The bleeding was a known risk of anticoagulation.

Our Counter: While bleeding is a known risk of anticoagulation, the standard of care requires the provider to minimize this risk through proper dosing, monitoring, and adjustment. If the bleeding was caused by a deviation from the standard of care (e.g., failure to monitor PT/INR, failure to adjust the dose, wrong concentration), the provider is liable.

Defense: The patient was non-compliant with their medication or diet.

Our Counter: While patient compliance is important, the provider must still meet the standard of care. If the patient was non-compliant, the provider should have addressed this through education, closer monitoring, and appropriate dose adjustment. We examine the MAR and laboratory results to determine whether the error was caused by provider negligence, not patient non-compliance.

Compensation Available

A successful anticoagulant error claim in New York can provide compensation for:

• Medical expenses: Including past and future medical care, surgeries, rehabilitation, and medications
• Lost wages and lost earning capacity: For time missed from work and reduced ability to work
• Pain and suffering: NY has no cap on non-economic damages
• Permanent disability: For brain damage from intracranial hemorrhage, organ damage, and other permanent conditions [Link to: /brain-injury/lawyer]
• Future medical care costs: Based on a life care plan, discounted to present value
• Loss of consortium: For the impact on family relationships
• Wrongful death damages: If the anticoagulant error caused death [Link to: /wrongful-death-lawyer]

What to Expect Working with MDLaw Firm

When you contact MDLaw Firm about a potential anticoagulant error case:

• Free Consultation: We listen to your story and review the basic facts.
• Immediate Deadline Assessment: We evaluate the 2.5-year statute of limitations and any municipal notice of claim deadlines.
• Record Retrieval: We obtain all medical records, including physician orders, the MAR, nursing notes, pharmacy records, laboratory results (aPTT, PT/INR), and imaging studies. [Link to: /resources/how-to-get-medical-records-for-a-lawsuit]
• Expert Review: We engage board-certified hematologists, hospital pharmacists, and critical care physicians to independently review the records.
• Causation Analysis: We establish that the anticoagulant error caused the harm.
• Life Care Plan: If the injury is permanent (brain damage from hemorrhage), we engage a life care planner to project future care needs. [Link to: /brain-injury/life-care-plan]
• Litigation: We file within the statute of limitations and handle all aspects of discovery and trial.
• Resolution: We pursue maximum compensation through settlement or verdict.

Frequently Asked Questions

The value of a medical malpractice case in New York depends on several factors, including the severity of the injury, the strength of liability evidence, and the economic and non-economic damages involved. New York is one of the few states with no caps on medical malpractice damages, meaning there is no artificial limit on what you can recover. Below are typical settlement ranges based on injury severity.